U.S. pharma big copyright scrapped two experimental weight loss tablets final 12 months—a as soon as-day by day capsule, lotiglipron, resulting from elevated liver enzymes plus a twice-every day tablet, danuglipron, resulting from solid Unwanted side effects—but CEO Albert Bourla has explained the company is set to “Perform and get” during